Skip to main content
SpringerLink
Log in

Outcome of Schizophrenia in Low- and Middle-Income Countries

  • Chapter
  • First Online:
Schizophrenia Treatment Outcomes

  • 2236 Accesses

Abstract

The study of course and outcome of schizophrenia continues to remain one of the most fascinating aspects of schizophrenia research. This starts with the very issue of the definition of outcome. Outcome being a multidimensional construct consisting of several independent domains, the assessment of different variables is a daunting task. Moreover, as with any population-based longitudinal study, long-term outcome research is marred by attrition and cost. Traditionally, clinical symptoms and functioning have been the principal outcome indicators. Disability, family burden, and quality of life are other outcome measures considered important in recent times. The results of earlier multicountry studies of unequivocal better outcome in developing studies have been scrutinized now and questioned. With changing demographics and sociocultural milieu in these countries, reevaluation is needed, keeping in mind some issues like human rights violation, mortality, and comorbidity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jablensky A, Hugler H, Von Cranach M, Kalinov K. Kraepelin revisited: a reassessment and statistical analysis of dementia praecox and manic-depressive insanity in 1908. Psychol Med. 1993;23(04):843–58.

    Article  PubMed  Google Scholar 

  2. Kuhn R, Cahn CH. Eugen Bleuler’s concepts of psychopathology. Hist Psychiatry. 2004;15(3):361–6.

    Article  PubMed  Google Scholar 

  3. Burns T. Evolution of outcome measures in schizophrenia. Br J Psychiatr. 2007;191:s1–6. Available at: http://bjp.rcpsych.org/content/191/50/s1.short.

    Article  Google Scholar 

  4. Cohen A, Patel V, Thara R, Gureje O. Questioning an axiom: better prognosis for schizophrenia in the developing world? Schizophr Bull. 2008;34(2):229–44.

    Article  PubMed  Google Scholar 

  5. Holla B, Thirthalli J. Course and outcome of schizophrenia in asian countries: review of research in the past three decades. Asian J Psychiatry. 2015;14:3–12.

    Article  Google Scholar 

  6. Davidson L, McGlashan TH. The varied outcomes of schizophrenia. Can J Psychiatr. 1997;42(1):34–43.

    Article  Google Scholar 

  7. Jobe TH, Harrow M. Long-term outcome of patients with schizophrenia: a review. Can J Psychiatr. 2005;50(14):892–900.

    Article  Google Scholar 

  8. Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G. One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry. 1994;151(10):1409–16.

    Article  PubMed  Google Scholar 

  9. McGlashan TH. A selective review of recent North American long-term followup studies of schizophrenia. Schizophr Bull. 1988;14(4):515.

    Article  PubMed  Google Scholar 

  10. Stephens JH. Long-term prognosis and followup in schizophrenia. Schizophr Bull. 1978;4(1):25.

    Article  PubMed  Google Scholar 

  11. Girolamo GD. WHO studies on schizophrenia: An overview of the results and their implications for the understanding of the disorder. The Psychotherapy Patient. 1996;9(3–4):213–31.

    Article  Google Scholar 

  12. Häfner H, An der Heiden W. The course of schizophrenia in the light of modern follow-up studies: the ABC and WHO studies. Eur Arch Psychiatry Clin Neurosci. 1999;249(Suppl 4):14–26. Available at: http://www.springerlink.com/index/QEWRD18K4QW6FUN9.pdf.

    Article  PubMed  Google Scholar 

  13. Leff J, Sartorius N, Jablensky A, Korten A, Ernberg G. The international pilot study of schizophrenia: five-year follow-up findings. Psychol Med. 1992;22(01):131–45.

    Article  PubMed  Google Scholar 

  14. Mason P, Harrison G, Glazebrook C, Medley I, Croudace T. The course of schizophrenia over 13 years. A report from the international study on schizophrenia (ISoS) coordinated by the World Health Organization. Br J Psychiatry. 1996;169(5):580–6.

    Article  PubMed  Google Scholar 

  15. Vijoy K. Determinants of outcome of severe mental disorder (DOSMeD). Recovery Schizophr Int Perspect Rep WHO Collab Proj. Int Study Schizophr. 2007;113.

    Google Scholar 

  16. Kulhara P. Outcome of schizophrenia: some transcultural observations with particular reference to developing countries. Eur Arch Psychiatry Clin Neurosci. 1994;244(5):227–35.

    Article  PubMed  Google Scholar 

  17. Patel V, Cohen A, Thara R, Gureje O. Is the outcome of schizophrenia really better in developing countries? Rev Bras Psiquiatr. 2006;28(2):149–52.

    Article  PubMed  Google Scholar 

  18. Bowie CR, Harvey PD. Cognitive deficits and functional outcome in schizophrenia. Neuropsychiatr Dis Treat. 2006;2(4):531.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Nuechterlein KH, Subotnik KL, Green MF, Ventura J, Asarnow RF, Gitlin MJ, et al. Neurocognitive predictors of work outcome in recent-onset schizophrenia. Schizophr Bull. 2011;37(suppl 2):S33–40.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper JE, et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl. 1992;20:1–97.

    Article  PubMed  Google Scholar 

  21. Verghese A, Dube KC, John J, Menon DK, Menon MS, Rajkumar S, et al. Factors associated with the course and outcome of schizophrenia. Indian J Psychiatry. 1985;27(3):201.

    PubMed  PubMed Central  Google Scholar 

  22. Thara R. Twenty-year course of schizophrenia: the Madras Longitudinal Study. Can J Psychiatr. 2004;49(8):564–9.

    Article  Google Scholar 

  23. Teferra S, Shibre T, Fekadu A, Medhin G, Wakwoya A, Alem A, et al. Five-year mortality in a cohort of people with schizophrenia in Ethiopia. BMC Psychiatry. 2011;11(1):165.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Mueser KT, Salyers MP, Mueser PR. A prospective analysis of work in schizophrenia. Schizophr Bull. 2001;27(2):281–96.

    Article  PubMed  Google Scholar 

  25. Srinivasan TN, Thara R. How do men with schizophrenia fare at work? A follow-up study from India. Schizophr Res. 1997;25(2):149–54.

    Article  PubMed  Google Scholar 

  26. Padmavathi R, Rajkumar S, Srinivasan TN. Schizophrenic patients who were never treated–a study in an Indian urban community. Psychol Med. 1998;28(05):1113–7.

    Article  PubMed  Google Scholar 

  27. Tsoi WF, Wong KE. A 15-year follow-up study of Chinese schizophrenic patients. Acta Psychiatr Scand. 1991;84(3):217–20.

    Article  PubMed  Google Scholar 

  28. Nanko S, Moridaira J. Reproductive rates in schizophrenic outpatients. Acta Psychiatr Scand. 1993;87(6):400–4.

    Article  PubMed  Google Scholar 

  29. Harrison G, Hopper KIM, Craig T, Laska E, Siegel C, Wanderling J, et al. Recovery from psychotic illness: a 15-and 25-year international follow-up study. Br J Psychiatry. 2001;178(6):506–17.

    Article  PubMed  Google Scholar 

  30. Thara R, Eaton WW. Outcome of schizophrenia: the Madras longitudinal study. Aust N Z J Psychiatry. 1996;30(4):516–22.

    Article  PubMed  Google Scholar 

  31. Thara R, Kamath S, Kumar S. Women with schizophrenia and broken marriages-doubly disadvantaged? Part II: family perspective. Int J Soc Psychiatry. 2003;49(3):233–40.

    Article  PubMed  Google Scholar 

  32. Grossman LS, Harrow M, Rosen C, Faull R. Sex differences in outcome and recovery for schizophrenia and other psychotic and nonpsychotic disorders. Psychiatr Serv. 2006;57(6):844–50.

    Article  PubMed  Google Scholar 

  33. Goldstein JM. Gender differences in the course of schizophrenia. Am J Psychiatry. 1988;145(6):684–9.

    Article  PubMed  Google Scholar 

  34. Seeman MV. Current outcome in schizophrenia: women vs men. Acta Psychiatr Scand. 1986;73(6):609–17.

    Article  PubMed  Google Scholar 

  35. Thara R, Rajkumar S. Gender differences in schizophrenia: results of a follow-up study from India. Schizophr Res. 1992;7(1):65–70.

    Article  PubMed  Google Scholar 

  36. Thara R, Henrietta M, Joseph A, Rajkumar S, Eaton WW. Ten-year course of schizophrenia—the Madras longitudinal study. Acta Psychiatr Scand. 1994;90(5):329–36.

    Article  PubMed  Google Scholar 

  37. Hopper K. Recovery from schizophrenia: an international perspective: a report from the WHO Collaborative Project, the international study of schizophrenia. New York: Oxford University Press; 2007.

    Google Scholar 

  38. Ran M, Xiang M, Huang M, Shan Y. Natural course of schizophrenia: 2-year follow-up study in a rural Chinese community. Br J Psychiatry. 2001;178(2):154–8.

    Article  PubMed  Google Scholar 

  39. Ohaeri JU. Long-term outcome of treated schizophrenia in a Nigerian cohort: retrospective analysis of 7-year follow-ups. J Nerv Ment Dis. 1993;181(8):514–6.

    Article  PubMed  Google Scholar 

  40. Kebede D, Alem A, Shibre T, Negash A, Deyassa N, Beyero T, et al. Short-term symptomatic and functional outcomes of schizophrenia in Butajira, Ethiopia. Schizophr Res. 2005;78(2):171–85.

    Article  PubMed  Google Scholar 

  41. Patel V, Farooq S, Thara R. What is the best approach to treating schizophrenia in developing countries? PLoS Med. 2007;4(6):e159.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002;63(10):892–909.

    Article  PubMed  Google Scholar 

  43. Falloon IR, Boyd JL, McGill CW, Razani J, Moss HB, Gilderman AM. Family management in the prevention of exacerbations of schizophrenia: a controlled study. N Engl J Med. 1982;306(24):1437–40.

    Article  PubMed  Google Scholar 

  44. Glynn SM, Cohen AN, Dixon LB, Niv N. The potential impact of the recovery movement on family interventions for schizophrenia: opportunities and obstacles. Schizophr Bull. 2006;32(3):451–63.

    Article  PubMed  PubMed Central  Google Scholar 

  45. García JIR, Chang CL, Young JS, López SR, Jenkins JH. Family support predicts psychiatric medication usage among Mexican American individuals with schizophrenia. Soc Psychiatry Psychiatr Epidemiol. 2006;41(8):624–31.

    Article  Google Scholar 

  46. Clark RE. Family support and substance use outcomes for persons with mental illness and substance use disorders. Schizophr Bull. 2001;27(1):93.

    Article  PubMed  Google Scholar 

  47. Thara R, Srinivasan TN. How stigmatising is schizophrenia in India? Int J Soc Psychiatry. 2000;46(2):135–41.

    Article  PubMed  Google Scholar 

  48. Phillips MR, Pearson V, Li F, Xu M, Yang L. Stigma and expressed emotion: a study of people with schizophrenia and their family members in China. Br J Psychiatry. 2002;181(6):488–93.

    Article  PubMed  Google Scholar 

  49. Gureje O, Cohen A. Differential outcome of schizophrenia: where we are and where we would like to be. Br J Psychiatry. 2011;199(3):173–5. Available at: http://bjp.rcpsych.org/content/199/3/173.short.

    Article  PubMed  Google Scholar 

  50. Haro JM, Novick D, Bertsch J, Karagianis J, Dossenbach M, Jones PB. Cross-national clinical and functional remission rates: worldwide schizophrenia outpatient health outcomes (W-SOHO) study. Br J Psychiatry J Ment Sci. 2011;199(3):194–201.

    Article  Google Scholar 

  51. Thara R, Greeshma M. Course and outcome of schizophrenia. Int Rev Psychiatry. 2012;24(5):417–22.

    Article  Google Scholar 

Download references

Acknowledgment

This work was supported by India-US Fogarty Training in Chronic Non-Communicable Disorders and Diseases Across Lifespan Grant # 1D43TW009120 (Raghavan, Fellow; LB Cottler, PI).

Author information

Authors and Affiliations

  1. Schizophrenia Research Foundation, Department of Psychiatry, Chennai, Tamil Nadu, India

    Thara Rangaswamy, Greeshma Mohan & Vijaya Raghavan

Authors
  1. Thara Rangaswamy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Greeshma Mohan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vijaya Raghavan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thara Rangaswamy .

Editor information

Editors and Affiliations

  1. Lawson Health Research Institute, Western University Lawson Health Research Institute, London, ON, Canada

    Amresh Shrivastava

  2. Lokmanya Tilak Municipal Medical College, De Sousa Foundation, Mumbai, India

    Avinash De Sousa

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rangaswamy, T., Mohan, G., Raghavan, V. (2020). Outcome of Schizophrenia in Low- and Middle-Income Countries. In: Shrivastava, A., De Sousa, A. (eds) Schizophrenia Treatment Outcomes. Springer, Cham. https://doi.org/10.1007/978-3-030-19847-3_4

Download citation

Publish with us

Policies and ethics

Search

Navigation